• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


3.3250 USD 0.0050 0.15%

As of 14:41:56 ET on 04/17/2014.

Snapshot for Exelixis Inc (EXEL)

Open: 3.2800 Day's Range: 3.2589 - 3.4400 Volume: 1,986,585
Previous Close: 3.3200 52wk Range: 3.0200 - 8.4100 1-Yr Rtn: -31.20%

Stock Chart for EXEL

No chart data available.
  • EXEL:US 3.3266
  • 1D
  • 1M
  • 1Y
Interactive EXEL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EXEL

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.3249
Est. EPS (USD) (12/2014) -1.4990
Est. PEG Ratio -
Market Cap (M USD) 662.66
Shares Outstanding (M) 194.61
30 Day Average Volume 7,416,106
Price/Book (mrq) 9.2771
Price/Sale (ttm) 19.5510
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EXEL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for EXEL

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.

Michael M MorrisseyPresident/CEOFrank L KarbeExec VP/CFO
J Scott GarlandExec VP/Chief Commercial OfcrGisela M SchwabExec VP/Chief Medical Officer
More Company Profile & Key Executives for EXEL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil